Page last updated: 2024-08-26

cp-55,940 and am 1241

cp-55,940 has been researched along with am 1241 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Futaki, N; Iida, I; Ishizaka, T; Ohta, H; Saito, S; Tatsuzuki, M; Toda, Y; Tomishima, Y; Yamaguchi, T; Yoshinaga, M1
Astruc-Diaz, F; Brown, DL; Diaz, P; Naguib, M; Pan, HM; Xu, J1
Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A1
Buzard, DJ; Han, S; Jones, RM; Thatte, J1

Reviews

1 review(s) available for cp-55,940 and am 1241

ArticleYear
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
    Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21

    Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity

2013

Other Studies

3 other study(ies) available for cp-55,940 and am 1241

ArticleYear
Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action.
    Bioorganic & medicinal chemistry, 2008, Feb-01, Volume: 16, Issue:3

    Topics: Animals; Humans; Imines; Male; Molecular Structure; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2008
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
    Journal of medicinal chemistry, 2008, Aug-28, Volume: 51, Issue:16

    Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Drug Design; Humans; Hydrazones; Isatin; Neuralgia; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; X-Ray Diffraction

2008
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism

2011